PharmaShots Weekly Snapshot (March 02-06, 2020)
Published: Mar 06, 2020 | Tags: Mount Sinai, Signs, Multi-Year, Collaboration, Harbour BioMed, Develop, Novel Biotherapies, Multiple Cancer Indications, COVID-19
Published: Mar 06, 2020 | Tags: AstraZeneca, Reports, Results, Imfinzi, Tremelimumab, P-III, DANUBE, Study, Unresectable, Stage IV, Bladder Cancer
Published: Mar 05, 2020 | Tags: Allergan, Durysta, bimatoprost implant, Receives, US, FDA, Approval, First, Intracameral, Biodegradable, Sustained-Release Implant, Patients, OAG, OHT
Published: Mar 05, 2020 | Tags: Zydus, Saroglitazar, Receives, DCGI, Approval, World, First Therapy, Non-Cirrhotic, NASH, India
Published: Mar 05, 2020 | Tags: Novartis, Enters, Four-Year, Collaboration, Orionis Biosciences, Tackle, Intractable, Disease Targets
6. The US FDA Informs About Cybersecurity Vulnerabilities in Medical Devices with Bluetooth Low Energy
Published: Mar 04, 2020 | Tags: US, FDA, Informs, About, Cybersecurity Vulnerabilities, Medical Devices, Bluetooth Low Energy
Published: Mar 05, 2020 | Tags: Heat Biologics, Signs, Research Collaboration, University of Miami, Develop, Vaccine, Against, COVID-19
8. Zuellig Pharma Acquires Alliance Pharma (Cambodge) to Bolster its Presence in Indochina
Published: Mar 05, 2020 | Tags: Zuellig Pharma, Acquires, Alliance Pharma, Cambodge, Bolster, Presence, Indochina
9. Roches Actemra (tocilizumab) Receives Approval to Combat Coronavirus Complications in China
Published: Mar 04, 2020 | Tags: Roche, Actemra, tocilizumab, Receives, Approval, Combat, Coronavirus Complications, China
Published: Mar 04, 2020 | Tags: Alopexx, Signs, Exclusive, License Agreement, Beijing Shenogen Pharma, Develop, Commercialize, DI-LEU16-IL2, B-Cell Lymphomas, China, Asia
Published: Mar 04, 2020 | Tags: Allergan, Editas, Report, First Patient Dosing, P-I/II, BRILLIANCE Study, AGN-151587, EDIT-101, Treat, LCA10
12. Vir and Alnylam Expand their 2017 License Agreement to Target COVID-19
Published: Mar 04, 2020 | Tags: Vir, Alnylam, Expand, 2017, License Agreement, Target, COVID-19
Published: Mar 04, 2020 | Tags: Janssen, Reports, Submission, MAA, EMA, Ponesimod, Treat, Patients, Relapsing Multiple Sclerosis
??14. Iktos and SRI Collaborate to Accelerate Discovery and Development of Novel Anti-Viral Therapies
Published: Mar 03, 2020 | Tags: Iktos, SRI, Collaborate, Accelerate, Discovery, Development, Novel, Anti-Viral Therapies
Published: Mar 03, 2020 | Tags: Alnylam, Givlaari, givosiran, Receives, EC, Approval, Acute Hepatic Porphyria, AHP, Adults, Adolescents
16. Takeda to Initiate the Development of Plasma-Derived Therapy to Treat Corona Virus (COVID-19)
Published: Mar 04, 2020 | Tags: Takeda, Initiate, Development, Plasma-Derived Therapy, Treat, Corona Virus, COVID-19
Published: Mar 03, 2020 | Tags: Roche, Elecsys GALAD scores, Receives, US, FDA, Breakthrough Device Designation, Earlier Diagnosis, Hepatocellular Carcinoma
18. BMS Collaborates with Voluntis to Co-Develop Digital Therapies to Treat Cancer Indications
Published: Mar 03, 2020 | Tags: BMS, Collaborates, Voluntis, Co-Develop, Digital Therapies, Cancer
Published: Mar 03, 2020 | Tags: Novartis, Mayzent, Receives, Health Canada, Approval, Secondary Progressive Multiple Sclerosis, Active Disease
Published: Mar 02, 2020 | Tags: Lucid Diagnostics, Collaborates, University of Pennsylvania, Evaluate, EsoCheck, Patients, Eosinophilic Esophagitis
Published: Mar 03, 2020 | Tags: Genentech, Esbriet, pirfenidone, Receives, FDA, Breakthrough Therapy Designation, Unclassifiable, Interstitial Lung Disease
22. ? Insulet to Halt Study of Omnipod Horizon Due to Software Anomaly
Published: Mar 03, 2020 | Tags: Insulet, Discontinue, Study, Omnipod Horizon, Software Anomaly
23. Thermo Fisher Scientific to Acquire QIAGEN for ~$11.5B
Published: Mar 03, 2020 | Tags: Thermo Fisher Scientific, Acquire, QIAGEN, ~$11.5B
Published: Mar 02, 2020 | Tags: Sanofi, Sarclisa, isatuximab-irfc, Receives, US, FDA, Approval, Relapsed Refractory Multiple Myeloma
Published: Mar 02, 2020 | Tags: uniQure, Signs, Exclusive, Research, License Agreement, Gen-X, Develop, Novel Synthetic Promoters
Published: Mar 02, 2020 | Tags: Pfizer, Eli Lilly, Report, US, FDA, Acceptance, BLA, Tanezumab, Treat, Chronic Pain, Moderate-to-Severe, Osteoarthritis
27. Gilead to Acquire Forty Seven for $4.9B
Published: Mar 02, 2020 | Tags: Gilead, Acquire, Forty Seven, $4.9B
Published: Mar 02, 2020 | Tags: Takeda, Divest, Portfolio, Select OTC, Non-Core Assets, Hypera Pharma, Latin America, $825M
29. Medexus Acquires Aptevo BioTherapeutics for its Hematology Asset IXINITY
Published: Feb 28, 2020 | Tags: Medexus, Acquires, Aptevo BioTherapeutics, Hematology Asset, IXINITY
Published: Feb 28, 2020 | Tags: Boehringer Ingelheim, Nintedanib, Receives, CHMP, Positive Opinion, Treat, Systemic Sclerosis-Associated Interstitial Lung Disease
Published: Mar 02, 2020 Tags: Merck KGaA, ERBITUX, cetuximab, Receives, NMPA, Approval, 1L, Treatment, Recurrent/ Metastatic, Squamous Cell Carcinoma of Head and Neck
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com